IVVD Q1 2025 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena

IVVDInvivyd, Inc.

$257M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M

Gross Profit

$10M92.6% margin

Operating Income

-$17M-149.7% margin

Net Income

-$16M-144.1% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

-18.2%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$104M

Total Liabilities

$50M

Stockholders' Equity

$54M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$0	—
Gross Profit	$10M	$0	—
Operating Income	-$17M	-$46M	+63.3%
Net Income	-$16M	-$43M	+62.6%

Revenue Segments

Product

$11M100%